Thomas E Hills

Macrophages and their interactions with oncolytic viruses.

L. Seymour, K. Fisher, Philip G Jakeman, 2015, Current opinion in pharmacology.

A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response.

L. Seymour, R. Carlisle, Prateek S. Katti, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Recombinant viral vaccines for cancer.

L. Seymour, K. Fisher, R. Cawood, 2012, Trends in molecular medicine.

Supplementary Text and Figures to In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity

Michael Y. Gerner, Kylie M. Quinn, Janine K. Tom, 2015 .

In vivo characterization of the physicochemical properties of TLR agonist delivery that enhance vaccine immunogenicity

Michael Y. Gerner, Kylie M. Quinn, Janine K. Tom, 2015, Nature Biotechnology.

A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+ T Helper Cells to Confirm B Cell Activation

P. Klenerman, L. Seymour, R. Carlisle, 2016, PloS one.

Improved in vitro human tumor models for cancer gene therapy.

L. Seymour, K. Fisher, Philip G Jakeman, 2015, Human gene therapy.